'Practical management of suspected hypersensitivity reactions to anti‐tuberculosis drugs.’

2021 ◽  
Author(s):  
WH Bermingham ◽  
R Bhogal ◽  
S Nagarajan ◽  
L Mutlu ◽  
RM El‐Shabrawy ◽  
...  
Keyword(s):  
Hypersensitivity Reactions ◽  
Practical Management

A case of erythritol allergy in a girl with hypersensitivity reactions to TAMIFLU® dry syrup

2018 ◽  
Vol 32 (2) ◽  
pp. 236-240
Author(s):  
Kasumi Tashiro ◽  
Eriko Oozono ◽  
Ai Ohnishi ◽  
Michiyo Sasaki ◽  
Fumiko Shibata ◽  
...  
Keyword(s):  
Hypersensitivity Reactions

Non–β-Lactam Antibiotic Hypersensitivity Reactions

PEDIATRICS ◽  
2020 ◽  
Vol 146 (Supplement 4) ◽  
pp. S335.2-S336
Author(s):  
Alex Qian ◽  
Susan Laubach
Keyword(s):  
Hypersensitivity Reactions ◽  
Lactam Antibiotic

Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions

2021 ◽  
Vol 42 (1) ◽  
pp. 16-21 ◽  
Author(s):  
Anna R. Wolfson ◽  
Aleena Banerji
Keyword(s):  
Negative Impact ◽  
Skin Testing ◽  
Drug Hypersensitivity ◽  
Clinical History ◽  
Hypersensitivity Reactions ◽  
Causative Drug ◽  
Care Assessment ◽  
Drug Hypersensitivity Reactions ◽  
Drug Challenge ◽  
Drug Challenges

Immediate hypersensitivity to drugs is characterized by symptoms such as hives, swelling, and wheezing. To prevent a negative impact on care, assessment by an allergist is important. Evaluation requires a clear clinical history, but it is often lacking or vague, which makes a diagnosis difficult. Allergists instead can use skin testing and drug challenge to evaluate drug hypersensitivity reactions, which help the patient and provider understand the causative drug(s) and, more importantly, enables the use of the exonerated drug(s). Although penicillin skin testing is standardized, well described, and widely used, skin testing for most other drugs requires the use of a nonirritating skin testing concentration that can have a low negative predictive value. Drug challenges are the criterion standard for confirming tolerance. The allergist must obtain an in-depth clinical history and then follow with skin testing and/or drug challenges when indicated to determine which drugs can be de-labelled and which should be avoided. In this review, we focused on the evaluation of drug hypersensitivity reactions to antibiotics, perioperative agents, biologics, and chemotherapeutics.

Hypersensitivity reactions to ophthalmic solutions – short update

Alergologia ◽  
2020 ◽  
Vol 3 (4) ◽  
pp. 142
Author(s):  
Larisa Ionela Ştefănescu ◽  
Elena Cristina Bălă ◽  
Roxana Silvia Bumbăcea
Keyword(s):  
Hypersensitivity Reactions ◽  
Ophthalmic Solutions

Hypersensitivity reactions induced by antiretroviral agents

Alergologia ◽  
2017 ◽  
Vol 1 (1) ◽  
Author(s):  
Corina Bocșan ◽  
Adriana Muntean ◽  
Anca Buzoianu
Keyword(s):  
Hypersensitivity Reactions ◽  
Antiretroviral Agents
Sign in / Sign up

Export Citation Format

Share Document